Inhaled ß2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease.

MLA

Cazzola M, et al. “Inhaled SS2-Adrenoceptor Agonists: Cardiovascular Safety in Patients with Obstructive Lung Disease.” Drugs, vol. 65, no. 12, June 2005, pp. 1595–610. EBSCOhost, https://doi.org/10.2165/00003495-200565120-00001.

APA

Cazzola M, Matera MG, & Donner CF. (2005). Inhaled ß2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease. Drugs, 65(12), 1595–1610. https://doi.org/10.2165/00003495-200565120-00001

Chicago

Cazzola M, Matera MG, and Donner CF. 2005. “Inhaled SS2-Adrenoceptor Agonists: Cardiovascular Safety in Patients with Obstructive Lung Disease.” Drugs 65 (12): 1595–1610. doi:10.2165/00003495-200565120-00001.